Blue Water Life Science Advisors, LP Natera, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q2 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Natera, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 503,094 shares of NTRA stock, worth $62.5 Million. This represents 52.98% of its overall portfolio holdings.
Number of Shares
503,094
Previous 503,094
-0.0%
Holding current value
$62.5 Million
Previous $46 Million
18.4%
% of portfolio
52.98%
Previous 43.28%
Shares
12 transactions
Others Institutions Holding NTRA
# of Institutions
511Shares Held
121MCall Options Held
412KPut Options Held
270K-
Vanguard Group Inc Valley Forge, PA11.3MShares$1.4 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$841 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY6.07MShares$753 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY5.26MShares$653 Million2.83% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.46MShares$554 Million2.34% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $12B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...